Skip to content

Clinical trials

Completed Pathologic Processes trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Status: Completed Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20141
20151
20171
20182
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neuroscience Trials Australia2
Vertex Pharmaceuticals Incorporated2
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
KAI Pharmaceuticals1
Medicines for Malaria Venture1
Pfizer1
University of Washington, the Collaborative Health Studies Coordinating Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes9
Cardiovascular Diseases3
Cystic Fibrosis3
Genetic Diseases, Inborn3
Lung Diseases3
Pancreatic Diseases3
Respiratory Tract Diseases3
Brain Diseases2
Brain Infarction2
Brain Ischemia2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.